Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Enhancement of NAD⁺-dependent SIRT1 deacetylase activity by methylselenocysteine resets the circadian clock in carcinogen-treated mammary epithelial cells.

Fang M, Guo WR, Park Y, Kang HG, Zarbl H.

Oncotarget. 2015 Dec 15;6(40):42879-91. doi: 10.18632/oncotarget.6002.

2.

Sleep interruption associated with house staff work schedules alters circadian gene expression.

Fang MZ, Ohman-Strickland P, Kelly-McNeil K, Kipen H, Crabtree BF, Lew JP, Zarbl H.

Sleep Med. 2015 Nov;16(11):1388-1394. doi: 10.1016/j.sleep.2015.06.011. Epub 2015 Jul 23.

3.

Effects of Selenium Yeast on Oxidative Stress, Growth Inhibition, and Apoptosis in Human Breast Cancer Cells.

Guo CH, Hsia S, Shih MY, Hsieh FC, Chen PC.

Int J Med Sci. 2015 Sep 5;12(9):748-58. doi: 10.7150/ijms.12177. eCollection 2015.

4.

Protective Role of Selenium Compounds on the Proliferation, Apoptosis, and Angiogenesis of a Canine Breast Cancer Cell Line.

Liu Y, Li W, Guo M, Li C, Qiu C.

Biol Trace Elem Res. 2016 Jan;169(1):86-93. doi: 10.1007/s12011-015-0387-3. Epub 2015 Jun 9.

PMID:
26051789
5.

Methylselenocysteine resets the rhythmic expression of circadian and growth-regulatory genes disrupted by nitrosomethylurea in vivo.

Fang MZ, Zhang X, Zarbl H.

Cancer Prev Res (Phila). 2010 May;3(5):640-52. doi: 10.1158/1940-6207.CAPR-09-0170. Epub 2010 Apr 27.

6.

Chemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue.

Zhang X, Zarbl H.

Cancer Prev Res (Phila). 2008 Jul;1(2):119-27. doi: 10.1158/1940-6207.CAPR-08-0036.

7.

Combination of methylselenocysteine with tamoxifen inhibits MCF-7 breast cancer xenografts in nude mice through elevated apoptosis and reduced angiogenesis.

Li Z, Carrier L, Belame A, Thiyagarajah A, Salvo VA, Burow ME, Rowan BG.

Breast Cancer Res Treat. 2009 Nov;118(1):33-43. doi: 10.1007/s10549-008-0216-x. Epub 2008 Oct 15.

PMID:
18855134
8.

Differential sensitivity of various human tumour-derived cell types to apoptosis by organic derivatives of selenium.

Jariwalla RJ, Gangapurkar B, Nakamura D.

Br J Nutr. 2009 Jan;101(2):182-9. doi: 10.1017/S0007114508998305. Epub 2008 Jun 13.

PMID:
18549510
10.

Subchronic oral toxicity studies of Se-methylselenocysteine, an organoselenium compound for breast cancer prevention.

Johnson WD, Morrissey RL, Kapetanovic I, Crowell JA, McCormick DL.

Food Chem Toxicol. 2008 Mar;46(3):1068-78. Epub 2007 Nov 12.

11.

Chemopreventive effect of selenium-enriched Japanese radish sprout against breast cancer induced by 7,12-dimethylbenz[a]anthracene in rats.

Yamanoshita O, Ichihara S, Hama H, Ichihara G, Chiba M, Kamijima M, Takeda I, Nakajima T.

Tohoku J Exp Med. 2007 Jun;212(2):191-8.

12.

Se-methylselenocysteine inhibits phosphatidylinositol 3-kinase activity of mouse mammary epithelial tumor cells in vitro.

Unni E, Koul D, Yung WK, Sinha R.

Breast Cancer Res. 2005;7(5):R699-707. Epub 2005 Jul 6.

13.

Osteopontin is a potential target gene in mouse mammary cancer chemoprevention by Se-methylselenocysteine.

Unni E, Kittrell FS, Singh U, Sinha R.

Breast Cancer Res. 2004;6(5):R586-92. Epub 2004 Jul 29.

14.

Mechanisms of mammary cancer chemoprevention by organoselenium compounds.

El-Bayoumy K, Sinha R.

Mutat Res. 2004 Jul 13;551(1-2):181-97. Review.

PMID:
15225592
15.

New concepts in selenium chemoprevention.

Ip C, Dong Y, Ganther HE.

Cancer Metastasis Rev. 2002;21(3-4):281-9. Review.

PMID:
12549766
16.

Se-methylselenocysteine: a new compound for chemoprevention of breast cancer.

Medina D, Thompson H, Ganther H, Ip C.

Nutr Cancer. 2001;40(1):12-7. Review.

PMID:
11799917
17.
18.

Combination of blocking agents and suppressing agents in cancer prevention.

Ip C, Ganther HE.

Carcinogenesis. 1991 Feb;12(2):365-7.

PMID:
1899813
19.

Chemical form of selenium, critical metabolites, and cancer prevention.

Ip C, Hayes C, Budnick RM, Ganther HE.

Cancer Res. 1991 Jan 15;51(2):595-600.

Supplemental Content

Loading ...
Support Center